Cell Banking Outsourcing Market By Type (Master Cell Banking, Viral Cell Banking, Working Cell Banking); By Product (Cord Cell Banking, Adult Stem Cell Banking, IPS Stem Cell Banking, Embryonic Stem Cell Banking, IPS Stem Cell Banking); By Cell Type (Stem Cell, Non-Stem Cell); By Phase (Bank Storage, Bank Preparation, Bank Characterization & Testing); By Region, Segments & Forecast, 2018 - 2025

报告摘要

据估计，全球电池银行外包市场估计2018年至2025年的CAGR成长为26.6％。观察到对细胞银行业务的偏好，因为它是生命科学中最有前途和最新的领域。细胞银行是一个完全表征，记录的，专注于各种关键属性，以迁移任何生物产品的风险相关产品安全性。此外，提供细胞银行服务的公司必须意识到提供的服务遵循FDA提到的CGMPS规则。必威开户注册由于越来越多的临床试验越来越多的临床试验越来越多的应用促使近年来干细胞银行的市场。人胚胎干细胞具有巨大的再生潜力，并且最近在再生药物中使用干细胞的方法对整个行业的生长产生了影响。

全球细胞银行外包市场增长主要由临床试验数量上升，这有助于揭露干细胞的潜力及其相关应用。同样，在一些发展中国家的干细胞银行业务上升，以及增加各国政府促进对干细胞孤立和相关效益的倡议的倡议，也是预计在预测期间影响该市场增长的因素。越来越多地应用干细胞用于开发个性化药物以最大限度地减少各种慢性疾病的传播，以及随着身体无法维持组织周转和止血的衰老结合，帮助研究人员专注于提供具有相对疗法的目标人群来提供相对疗法有效地在受损细胞上行动。因此，预计与干细胞应用相关的研究数量将支持预测期间的市场增长。此外，由于高级医学研究和提高人口的一般生活方式，增加了平均寿命，以及干细胞研究人员的直接法规创造了更大的市场空间。虽然，增加脂肪组织银行的增加也成为了一个主要的机会之一，其具有廉价的未来使用潜在的潜力。

Segment Analysis

The global cell banking outsourcing market is segmented on the basis of type, product, cell type, phase, and geography. On the basis of type of cell banking, the global cell banking outsourcing market is sub-segmented into master cell banking, viral cell banking, and working cell banking. Master cell banking segment is observed to hold the largest market share.

Based on product type, the global cell banking outsourcing market covers cord cell banking, adult stem cell banking, IPS stem cell banking, and embryonic stem cell banking. Cord cell banking accounts for the largest market share owing to the rising number of cord blood banks and cord blood banking services across the globe. Additionally, increasing number of genetic diseases that can be effectively treated by the isolated cord cells is expected to have a positive influence on the segment growth during forecast period. However, high cost incurred for isolation of cord cell and stringent government policies might hinder the market growth.

On the basis of cell type, the global cell banking outsourcing market is sub-segmented into stem cell and non-stem cell type. Stem cell segment to hold the major market share owing to factors such as increasing availability of stem cells from different organs and relative flexible use of these cells.

基于阶段，全球电池银行外包市场被分段为银行存储，银行准备和银行表征和测试。由于需要适当储存细胞和适当的维护先决条件，预计银行存储部门预计将受到重大的市场份额。此外，还预期保存这些分离细胞的冷冻保存技术的技术进步，以推动该市场的增长。预计将在即将到来的年度产生利润丰厚的市场机会，预计会增加越来越多的研究。

Cell Banking Outsourcing Market Scope

By Type	By Product Type	By Cell Type	按阶段类型	按地区
硕士银行银行 Viral Cell Banking Working Cell Banking	Cord Cell Banking Adult Stem Cell Banking IPS干细胞银行 胚胎干细胞	Stem Cell Non-stem Cell	银行存储 工作细胞库存储 Master Cell Bank Storage Cell Storage Stability Testing Bank Preparation 银行表征和测试	北美（美国，加拿大） 欧洲（德国，英国，法国，意大利，西班牙，比利时，俄罗斯，荷兰） 亚太地区（中国，日本，印度，澳大利亚，韩国，新加坡，马来西亚，印度尼西亚，泰国，菲律宾） 拉丁美洲（巴西，墨西哥，阿根廷） 中东和非洲（阿联酋，沙特阿拉伯，南非）

了解有关此报告的更多信息：request for sample pages

Regional Analysis

By geography, the global cell banking outsourcing market covers five major regions, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America cell bank outsourcing market to dominate this market in terms of revenue and market share during 2017. The growth of North American market is majorly driven due to increasing number biopharmaceutical companies and manufacturers in this region, and increasing awareness for the use of stem cells as therapeutics proteins and antibiotics. Moreover, presence of regulatory authorities that promotes continuous R&D activities, and increasing number of registrations by International Conference on Harmonization to also drive the market growth in North America. While, Asia Pacific is observed to be the fastest growing market during the forecast period. Growth in this region is attributed to the increase in life science sectors along with the help of supportive government initiatives pertaining to investment on biotechnology sector.

竞争分析

在全球经营的一些主要的关键球员Cell banking outsourcing market includes BioReliance, Covance, GlobalStem Inc., BSL Bioservice, Cleancells, Charles River Laboratories Lonza, Toxikon Corporation, Cryobanks International India, Wuxi Apptec, Reliance Life Sciences, LifeCell International Pvt. Ltd., BioOutsource (Sartorious), CordLife, PX’Therapeutics SA, SGS Life Sciences, Texcell, and Cryo-Cell International Inc.